<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dou DR</submitter><funding>National Institute of Arthritis and Musculoskeletal and Skin Diseases</funding><funding>Howard Hughes Medical Institute</funding><funding>Scleroderma Research Foundation</funding><funding>NIAMS NIH HHS</funding><funding>NIH</funding><funding>Kao Corporation</funding><pagination>733-749.e16</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10949934</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>187(3)</volume><pubmed_abstract>Autoimmune diseases disproportionately affect females more than males. The XX sex chromosome complement is strongly associated with susceptibility to autoimmunity. Xist long non-coding RNA (lncRNA) is expressed only in females to randomly inactivate one of the two X chromosomes to achieve gene dosage compensation. Here, we show that the Xist ribonucleoprotein (RNP) complex comprising numerous autoantigenic components is an important driver of sex-biased autoimmunity. Inducible transgenic expression of a non-silencing form of Xist in male mice introduced Xist RNP complexes and sufficed to produce autoantibodies. Male SJL/J mice expressing transgenic Xist developed more severe multi-organ pathology in a pristane-induced lupus model than wild-type males. Xist expression in males reprogrammed </pubmed_abstract><journal>Cell</journal><pubmed_title>Xist ribonucleoproteins promote female sex-biased autoimmunity.</pubmed_title><pmcid>PMC10949934</pmcid><funding_grant_id>R01 AR069572</funding_grant_id><funding_grant_id>K99 AR080218</funding_grant_id><funding_grant_id>T32 AR007422</funding_grant_id><funding_grant_id>R01-AR069572</funding_grant_id><funding_grant_id>K99/R00</funding_grant_id><funding_grant_id>T32 AR050942</funding_grant_id><pubmed_authors>Belk JA</pubmed_authors><pubmed_authors>Chung LS</pubmed_authors><pubmed_authors>Chang HY</pubmed_authors><pubmed_authors>Shah AA</pubmed_authors><pubmed_authors>Petri M</pubmed_authors><pubmed_authors>Chen DC</pubmed_authors><pubmed_authors>Li R</pubmed_authors><pubmed_authors>Chang S</pubmed_authors><pubmed_authors>Lundberg EK</pubmed_authors><pubmed_authors>Fiorentino DF</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Feng A</pubmed_authors><pubmed_authors>Abe BT</pubmed_authors><pubmed_authors>Kraft K</pubmed_authors><pubmed_authors>Yu B</pubmed_authors><pubmed_authors>Casey KM</pubmed_authors><pubmed_authors>Hellstrom C</pubmed_authors><pubmed_authors>Srinivasan S</pubmed_authors><pubmed_authors>Wutz A</pubmed_authors><pubmed_authors>Utz PJ</pubmed_authors><pubmed_authors>Goldman DW</pubmed_authors><pubmed_authors>Sjoberg R</pubmed_authors><pubmed_authors>Dou DR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Xist ribonucleoproteins promote female sex-biased autoimmunity.</name><description>Autoimmune diseases disproportionately affect females more than males. The XX sex chromosome complement is strongly associated with susceptibility to autoimmunity. Xist long non-coding RNA (lncRNA) is expressed only in females to randomly inactivate one of the two X chromosomes to achieve gene dosage compensation. Here, we show that the Xist ribonucleoprotein (RNP) complex comprising numerous autoantigenic components is an important driver of sex-biased autoimmunity. Inducible transgenic expression of a non-silencing form of Xist in male mice introduced Xist RNP complexes and sufficed to produce autoantibodies. Male SJL/J mice expressing transgenic Xist developed more severe multi-organ pathology in a pristane-induced lupus model than wild-type males. Xist expression in males reprogrammed </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2026-06-01T14:39:56.513Z</modification><creation>2025-04-03T23:22:35.937Z</creation></dates><accession>S-EPMC10949934</accession><cross_references><pubmed>38306984</pubmed><doi>10.1016/j.cell.2023.12.037</doi></cross_references></HashMap>